Post Subject #76   $18. PT > H.C. Wainwright analyst Andrew crudeoil24 03/29/22 02:55:43 PM #75   Needham Maintains Buy on PhaseBio Pharmaceuticals, Lowers Price crudeoil24 03/29/22 02:54:27 PM #74   I love the squeeze possibilities here. 24% New World Investor 03/03/21 11:13:08 AM #73   Still here :) vwlibra 02/11/21 09:10:30 AM #72   Where is everybody? This thing is finally starting blh28 02/10/21 02:44:32 PM #71   I like the large group of past Trials tcm55 10/01/20 12:44:44 PM #70   Gotta wait it out. anotherboat12 09/17/20 11:36:12 PM #69   Crickets....and these guys have the same drug as urgonnatrip 09/17/20 08:14:04 AM #68   Very professional. anotherboat12 09/15/20 12:33:05 PM #67   Very professional. anotherboat12 09/15/20 12:33:04 PM #66   CEO speaking tomorrow... urgonnatrip 09/14/20 08:08:56 PM #65   up 12%... urgonnatrip 09/14/20 01:57:43 PM #64   Yeah, if their IP position is tight, I urgonnatrip 09/12/20 06:20:57 PM #63   Its a different game right now for them. anotherboat12 09/08/20 09:30:16 AM #62   Agreed. Float is only 15M too. This stock Jama87 09/07/20 11:00:27 PM #61   These guys need to wake up and get urgonnatrip 09/07/20 10:01:28 PM #60   Ive emailed them and they have responded. anotherboat12 09/03/20 10:55:19 AM #59   Just would like to hear more from PHAS. urgonnatrip 09/03/20 10:43:02 AM #58   I will wait for the time in the anotherboat12 09/01/20 10:35:31 PM #57   PHAS not the talk of the town at urgonnatrip 09/01/20 09:46:41 PM #56   Thats why I like it. If that anotherboat12 08/31/20 03:34:25 PM #55   This board sure is quiet. urgonnatrip 08/31/20 02:19:12 PM #54   Doubtful. They both have orphan status and anotherboat12 08/29/20 05:12:41 PM #53   So will PHAS and RLFTF have a patent issue? urgonnatrip 08/29/20 04:50:27 PM #52   RLF’s success should be giving this significant interest. Jama87 08/28/20 01:14:24 PM #51   https://clinicaltrials.gov/ct2/show/NCT04433546?cond=PB1046&draw=2&rank=4 anotherboat12 08/19/20 05:27:48 PM #50   I think a lot of people will be anotherboat12 08/16/20 06:41:51 PM #49   Found this last night, definitely checking out. oatsuzn 08/14/20 11:16:44 AM #48   VIP is too old for a patent without anotherboat12 08/12/20 09:57:38 PM #47   But PHAS doesn’t have what Relief has! mikar 08/12/20 09:56:33 PM #46   Their recent earnings has suggested a BLA would anotherboat12 08/12/20 09:55:12 PM #45   Their drug won’t be reporting phase 2 until mikar 08/12/20 09:51:51 PM #44   RLFLF needs 2B in market cap to move anotherboat12 08/12/20 02:18:54 PM #43   Yeah, Im going to keep posting from time anotherboat12 08/12/20 02:09:57 PM #42   I see your posts are unfortunately being deleted Whalatane 08/12/20 02:03:50 PM #41   At least with Phase Bio, their share count anotherboat12 08/12/20 08:23:02 AM #40   IF, this VIP is the answer, there is anotherboat12 08/12/20 08:22:10 AM #39   Phase Bio has all the patents on their anotherboat12 08/12/20 08:21:20 AM #38   I see it’s a Sub Q injection with Whalatane 08/11/20 10:43:44 AM #37   Yes for their drug rlf-100. PB-1046 is anotherboat12 08/11/20 10:38:15 AM #36   It’s the FDA approval for the Covid indication Whalatane 08/11/20 10:35:39 AM #35   The share counts of RLFTF vs PHAS are anotherboat12 08/11/20 10:33:59 AM #34   What is the difference when PHAS has great anotherboat12 08/11/20 10:27:16 AM #33   RLFTF is FDA fast tracked with an Orphan Whalatane 08/11/20 10:24:40 AM #32   Buying this for the VIP covid treatment. anotherboat12 08/11/20 09:49:00 AM #31   DSG Supports PhaseBio Pharmaceuticals with Unified Clinical Trial vwlibra 07/20/20 09:56:25 AM #30   PhaseBio Doses First Patient in VANGARD Phase 2 vwlibra 07/17/20 02:09:44 PM #29   PHAS upgraded by Zacks from a “hold” rating vwlibra 07/16/20 08:46:31 AM #28   STIFEL NICOLAUS MAINTAINS THEIR BUY RATING ON PHASEBIO vwlibra 07/10/20 09:10:39 AM #27   Bump... TR analysts have this as a "strong vwlibra 07/08/20 10:22:24 AM Post Subject

© 2022 InvestorsHub.com, Inc.